Bimatoprost

5 trials SOphthalmology & ENT

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

0 Recruiting

5 Completed trials

3 Sponsors

10 Countries

Phase III

Phase IV

Phase III: 4 Phase IV: 1

Indications tested

Ocular hypertension 2

Sponsors using this IMP

AbbVie Deutschland GmbH & Co. KG 3 Genetic S.p.A. 1 Region Vaesterbotten 1

All trials

5 total

The Efficacy and Safety of Bimatoprost SR in Patients With Open-angle Glaucoma or Ocular Hypertension Ended

2024-519595-87-00 Phase III 1 country AbbVie Deutschland GmbH & Co. KG
Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomize… Ended

2023-510041-16-00 Phase IV 1 country Region Vaesterbotten
RANDOMIZED, OPEN LABEL, PARALLEL-GROUP, TWO-ARM, MULTICENTER STUDY WITH CLINICAL ENDPOINT COMPARING PRESERVATIVE FREE BIMATOPROST OPHTHALMIC… Ended

2023-504759-28-00 Phase III 1 country Genetic S.p.A.
An Extension Trial to Evaluate the Long-term Safety and Efficacy of Bimatoprost SR in Patients with Open Angle Glaucoma or Ocular Hypertensi… Ended

2023-504601-36-00 Phase III 4 countries AbbVie Deutschland GmbH & Co. KG
A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension Ended

2022-502380-37-00 Phase III 7 countries Abbvie Deutschland GmbH & Co. KG

Showing 1–5 of 5 trials

← All drugs A–Z